Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02480283 · ClinicalTrials.gov registry record
Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response
A clinical trial of Oxidative Stress and Cannabis Smoking, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT02480283: Recruiting study of Oxidative Stress and Cannabis Smoking, sponsored by University of Colorado, Denver.
NCT02480283 is a study of Oxidative Stress and Cannabis Smoking that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 100 participants, above the 83-participant average among 36 other Oxidative Stress trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02480283, a study of Oxidative Stress and Cannabis Smoking, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to evaluate the effects of chronic cannabis smoking on lung health by evaluating its effects on pulmonary health, lung physiology and alveolar macrophage function.
Primary Outcome
Alveolar macrophage phagocytosis, secretion of pro-inflammatory cytokines, and cellular apoptosis, both at baseline, and after stimulation with pathogen-associated molecular patterns.
Conditions Studied
Interventions
- PROCEDURE Bronchoscopy
- RADIATION Chest X-ray
- PROCEDURE Venipuncture
- PROCEDURE Intravenous Catheter
Study Locations (1)
Colorado
- University of Colorado, Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-11-11 |
| Est. Completion | 2027-07 |
What NCT02480283 shows while recruiting
NCT02480283 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 36 other Oxidative Stress trials with a reported enrollment target (20% higher).
The record links to 2 conditions, with Oxidative Stress appearing as the primary indexed condition, and to 4 interventions - of which Bronchoscopy is the first listed.
NCT02480283 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02480283 about?
NCT02480283 is a clinical study titled "Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response". This study plans to evaluate the effects of chronic cannabis smoking on lung health by evaluating its effects on pulmonary health, lung physiology and alveolar macrophage function.
What is the current status of trial NCT02480283?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2015-11-11. Estimated completion is 2027-07.
What conditions does trial NCT02480283 study?
This clinical trial studies the following conditions: Oxidative Stress, Cannabis Smoking.
What interventions are being tested in trial NCT02480283?
The interventions under investigation include: Bronchoscopy (PROCEDURE), Chest X-ray (RADIATION), Venipuncture (PROCEDURE), Intravenous Catheter (PROCEDURE).
Who is sponsoring clinical trial NCT02480283?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02480283 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oxidative Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02480283's enrollment target sits among peer trials
100 6th of 36 higher than 31 of 36 other Oxidative Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oxidative Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The ROAR Study: Reactive Oxygen Species and Reproduction
RECRUITING
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
RECRUITING · Phase 2
-
Impact of Haskap Berries on Recovery From High Intensity Resistance Training
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
-
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI